Testicular cancer treatment may be reduced without harm, new study hopes
NCT ID NCT06309745
First seen Mar 17, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study is testing whether men with stage II seminoma testicular cancer can receive less intensive treatment without harming their health. Researchers will track 30 patients in two UK hospitals to see if they are willing to join the study, how their cancer responds, and how their quality of life changes. The goal is to gather information to design a larger trial that could change standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEMINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barts and London Hospital NHS Trust
RECRUITINGLondon, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.